物质使用和相关疾病的生物治疗指南,第1部分:酒精中毒,第一次修订

M. Soyka, H. Kranzler, V. Hesselbrock, S. Kasper, J. Mutschler, H. Möller
{"title":"物质使用和相关疾病的生物治疗指南,第1部分:酒精中毒,第一次修订","authors":"M. Soyka, H. Kranzler, V. Hesselbrock, S. Kasper, J. Mutschler, H. Möller","doi":"10.1080/15622975.2016.1246752","DOIUrl":null,"url":null,"abstract":"Abstract These practice guidelines for the biological treatment of alcohol use disorders are an update of the first edition, published in 2008, which was developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). For this 2016 revision, we performed a systematic review (MEDLINE/PUBMED database, Cochrane Library) of all available publications pertaining to the biological treatment of alcoholism and extracted data from national guidelines. The Task Force evaluated the identified literature with respect to the strength of evidence for the efficacy of each medication and subsequently categorised it into six levels of evidence (A–F) and five levels of recommendation (1–5). Thus, the current guidelines provide a clinically and scientifically relevant, evidence-based update of our earlier recommendations. These guidelines are intended for use by clinicians and practitioners who evaluate and treat people with alcohol use disorders and are primarily concerned with the biological treatment of adults with such disorders.","PeriodicalId":22963,"journal":{"name":"The World Journal of Biological Psychiatry","volume":"95 1","pages":"119 - 86"},"PeriodicalIF":0.0000,"publicationDate":"2017-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"50","resultStr":"{\"title\":\"Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision\",\"authors\":\"M. Soyka, H. Kranzler, V. Hesselbrock, S. Kasper, J. Mutschler, H. Möller\",\"doi\":\"10.1080/15622975.2016.1246752\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract These practice guidelines for the biological treatment of alcohol use disorders are an update of the first edition, published in 2008, which was developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). For this 2016 revision, we performed a systematic review (MEDLINE/PUBMED database, Cochrane Library) of all available publications pertaining to the biological treatment of alcoholism and extracted data from national guidelines. The Task Force evaluated the identified literature with respect to the strength of evidence for the efficacy of each medication and subsequently categorised it into six levels of evidence (A–F) and five levels of recommendation (1–5). Thus, the current guidelines provide a clinically and scientifically relevant, evidence-based update of our earlier recommendations. These guidelines are intended for use by clinicians and practitioners who evaluate and treat people with alcohol use disorders and are primarily concerned with the biological treatment of adults with such disorders.\",\"PeriodicalId\":22963,\"journal\":{\"name\":\"The World Journal of Biological Psychiatry\",\"volume\":\"95 1\",\"pages\":\"119 - 86\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-02-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"50\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The World Journal of Biological Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/15622975.2016.1246752\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The World Journal of Biological Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15622975.2016.1246752","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 50

摘要

这些酒精使用障碍生物治疗实践指南是2008年第一版的更新版,第一版由世界生物精神病学学会联合会(WFSBP)的一个国际工作组制定。在2016年的修订中,我们对所有与酒精中毒生物治疗相关的现有出版物(MEDLINE/PUBMED数据库,Cochrane图书馆)进行了系统回顾,并从国家指南中提取了数据。工作组就每种药物疗效的证据强度对已确定的文献进行了评估,并随后将其分为六个证据级别(A-F)和五个推荐级别(1-5)。因此,目前的指南提供了我们早期建议的临床和科学相关的、基于证据的更新。这些指南旨在供评估和治疗酒精使用障碍患者的临床医生和从业人员使用,并主要关注患有此类障碍的成人的生物治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision
Abstract These practice guidelines for the biological treatment of alcohol use disorders are an update of the first edition, published in 2008, which was developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). For this 2016 revision, we performed a systematic review (MEDLINE/PUBMED database, Cochrane Library) of all available publications pertaining to the biological treatment of alcoholism and extracted data from national guidelines. The Task Force evaluated the identified literature with respect to the strength of evidence for the efficacy of each medication and subsequently categorised it into six levels of evidence (A–F) and five levels of recommendation (1–5). Thus, the current guidelines provide a clinically and scientifically relevant, evidence-based update of our earlier recommendations. These guidelines are intended for use by clinicians and practitioners who evaluate and treat people with alcohol use disorders and are primarily concerned with the biological treatment of adults with such disorders.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The role of the immune system in depersonalization disorder Downregulation of lncRNAs Gomafu, NONMMUT033604.2, and NONMMUT064397.2 in the hippocampus of mice with model of post-traumatic stress disorder Ketamine-induced changes in plasma brain-derived neurotrophic factor (BDNF) levels are associated with the resting-state functional connectivity of the prefrontal cortex Positive association between cerebral grey matter metabolism and dopamine D2/D3 receptor availability in healthy and schizophrenia subjects: An 18F-fluorodeoxyglucose and 18F-fallypride positron emission tomography study Extrapyramidal reactions following treatment with antidepressants: Results of the AMSP multinational drug surveillance programme
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1